Unofficial FDA What's New: Vaccines, Blood and Biologics Bot
fda-biologics-bot.bsky.social
Unofficial FDA What's New: Vaccines, Blood and Biologics Bot
@fda-biologics-bot.bsky.social
Posts from the FDA What's New: Vaccines, Blood and Bioligics. Not affiliated with the FDA. Bot will update once/day at midnight CST. For any questions, feature requests, or bug reports, please reach out to
@davidw1457.bsky.social
Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method
September 17, 2026 at 5:00 AM
FDA Scientific Public Workshop: Next-Generation Sequencing for Adventitious Agent Detection in Biologics – September 23, 2026 - 09/23/2026
September 17, 2026 at 5:00 AM
Clinical Trials: The Patient Experience - 04/13/2023
September 16, 2026 at 5:00 AM
FDA Expedited Investigational New Drug (IND) Pilot Program
September 16, 2026 at 5:00 AM
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products - 06/04/2026
September 16, 2026 at 5:00 AM
OTP Town Hall: Best Practices for Regulatory Interactions with OTP - 12/12/2024
September 16, 2026 at 5:00 AM
FDA Pharmacy Student Experiential Program
September 16, 2026 at 5:00 AM
FDA CBER Webinar: Human Gene Therapy Products Incorporating Human Genome Editing - 02/29/2024
September 16, 2026 at 5:00 AM
Finding Your Support Team While Participating in a Clinical Trial - 10/30/2024
September 16, 2026 at 5:00 AM
OTP Learn
September 16, 2026 at 5:00 AM
FDA CBER Webinar: Considerations for the Development of CAR T Cell Products - 03/07/2024
September 16, 2026 at 5:00 AM
Warrior Families: Advancing Regenerative Medicine Through Science - 10/05/2023
September 16, 2026 at 5:00 AM
Vaccines and Related Biological Products Advisory Committee October 1, 2026 Meeting Announcement - 10/01/2026
September 15, 2026 at 5:00 AM
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations - 09/29/2026
September 15, 2026 at 5:00 AM
Importance of Influenza Vaccination for Health Care Personnel
September 12, 2026 at 5:00 AM
Office of Therapeutic Products (OTP) Events, Meetings, and Workshops
September 12, 2026 at 5:00 AM
cobas Zika
September 11, 2026 at 5:00 AM
Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases - 09/20/2024
September 11, 2026 at 5:00 AM
Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates - 05/24/2022
September 11, 2026 at 5:00 AM
Center for Biologics Evaluation and Research (CBER) 2022 Science Symposium Meeting Agenda
September 11, 2026 at 5:00 AM
cobas Malaria
September 11, 2026 at 5:00 AM
Developing Vaccines for Fungal Diseases: Coccidioidomycosis/Valley Fever - 08/13/2024
September 11, 2026 at 5:00 AM
Information for Practitioners - FDA’s Regulatory Oversight of Regenerative Medicine Products - 11/17/2022
September 11, 2026 at 5:00 AM
Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants - 10/25/2024
September 11, 2026 at 5:00 AM
OTAT Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls - 09/22/2022
September 11, 2026 at 5:00 AM